IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY
I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE
CIV-2019-404-2640
[2025] NZHC 1793
BETWEEN DR SHIGY ALEX THACHANKARY
Plaintiff
AND
ANURAG RASELA
First Defendant
DR VANDANA RASELA
Second DefendantHOWARD C TONGE
Third DefendantFLAT BUSH MEDICAL CENTRE LIMITED
Fourth Defendant
UMANGA PATEL
Fifth Defendantcontinued: …/2
Hearing: 10 December 2024 Counsel:
A Barker KC and S F W McNulty for Plaintiff
A H Waalkens KC and J G Donkin for First and Second Defendants
No appearance for Third and Fourth Defendants D G Collecutt for Fifth Defendant
Judgment:
2 July 2025
JUDGMENT (No. 2) OF HARVEY J
This judgment is delivered by me on 2 July 2025 at 11.30am pursuant to r 11.5 of the High Court Rules
………………………………
Deputy Registrar
THACHANKARY v RASELA (NO. 2) [2025] NZHC 1793 [2 July 2025]
…/2
CIV-2020-404-1327
BETWEEN DR VANDANA RASELA
Second Defendant
ANDAUCKLAND CITY MEDICAL CLINICS LIMITED
First Defendant
TABLE OF CONTENTS
Introduction[1]
Agreed payments[6]
Issues[9]
FBMC’s submissions[11]
What equitable damages are appropriate regarding FBMC? [15]
Dr Thachankary’s submissions[15]
The Raselas’ submissions[18]
FBMC’s submissions[21]
Mr Patel’s submissions[23]
Discussion[24]
The fiduciary duties[26]
Establishing loss[29]
Would FBMC have been sold anyway?[33]
Would FBMC have been liable to pay for the Murphys Road construction costs?
[47]
Would FBMC have held a lease?[53]
Would Dr Thachankary be required to equalise the shareholder current accounts?
[57]
Quantum of equitable compensation[64]
Are exemplary damages justified? [65]
Dr Thachankary’s submissions[65]
The Raselas’ submissions[66]
Dr Thachankary’s reply submissions[69]
Legal principles [73]
Discussion[75]
Who should buy the shares in ACMC and at what price?[92] Application to adduce further evidence and for discovery — the Raselas’ submissions[93]
Application to adduce further evidence and for discovery — Dr Thachankary’s submissions[97]
Discussion[98]
Legal principles[103]Purchase by Dr Thachankary — Dr Thachankary’s submissions[105] Purchase by Dr Thachankary — The Raselas’ submissions[110] Purchase by Dr Thachankary — Dr Thachankary’s reply submissions[113]
Discussion[118]
Purchase by Dr Rasela — the Raselas’ submissions[124]
Purchase by Dr Rasela — Dr Thachankary’s submissions[127]
Discussion[129]
Decision[137]
Introduction
[1] At [151] of my judgment dated 22 August 2024 (the liability judgment), I invited further submissions on remedies. This was made against the background of the decision as a whole and, in particular, [147]–[150].1 Memoranda on Dr Thachankary’s claim for additional hours were also sought at [116]. Counsel’s submissions were then considered at a hearing held on 10 December 2024.
[2]In summary, Mr Barker KC for Dr Thachankary sought orders that:
(a)The Raselas and Mr Patel pay him $275,000 with interest under the Interest on Money Claims Act 2016 (IMCA) from 31 January 2020 until payment.
(b)The Raselas and Mr Patel pay him $50,000 in exemplary damages with interest under the IMCA from the date of judgment until payment.
(c)Auckland Central Medical Clinics Ltd (ACMC) pay Dr Thachankary
$660,956.43 with interest under the IMCA from the date of judgment until payment.
(d)ACMC pay Dr Thachankary for unpaid salary hours worked and for increased hourly rates from 1 August 2024 until the transfer of ACMC…
Continue reading Thachankary v Rasela
Sign in free to access the full text
- AGLC
- Thachankary v Rasela [2025] NZHC 1793
- Case
- [2025] NZHC 1793
- Decision Date
CaseChat Overview and Summary
The court found that the defendants breached their fiduciary duties and contractual obligations, leading to Dr Thachankary suffering a significant loss. The court awarded Dr Thachankary $257,276.74 in equitable damages for the loss of his half-share in Flat Bush Medical Centre Ltd (FBMC) and his loss of a business chance. Additionally, the court granted $10,000 in exemplary damages due to the defendants' outrageous conduct, which included executing lease and loan agreements without Dr Thachankary's knowledge and withholding his salary.
Regarding the purchase of ACMC shares, the court ruled that Dr Thachankary should purchase Dr Rasela's shares for 40 per cent of the agreed enterprise value ($471,200). If Dr Thachankary declined to purchase, Dr Rasela would have the option to purchase for 50 per cent of the agreed value ($589,000). If neither party purchased the shares, ACMC would be liquidated. The court also ordered various payments from ACMC to Dr Thachankary for unpaid salary and increased hourly rates, with interest.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.